SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Venture Partner Mike Grey named EY Entrepreneur Of The Year San Diego
News | 06. 24. 2014
Venture Partner Mike Grey named EY Entrepreneur Of The Year San Diego
